Difference between revisions of "Miettinen M, et al. Appl. Immunohistochem. Mol. Morphol. (2005) cited as Ref 735 in DOI: 10.1038/s41392-020-0110-5 (Q9998)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2005, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Published In Name String (P102): Appl. Immunohistochem. Mol. Morphol., #quickstatements; #temporary_batch_1590006349955) |
||
| Property / Published In Name String | |||
| + | Appl. Immunohistochem. Mol. Morphol. | ||
| Property / Published In Name String: Appl. Immunohistochem. Mol. Morphol. / rank | |||
| + | Normal rank | ||
Revision as of 21:10, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Miettinen M, et al. Appl. Immunohistochem. Mol. Morphol. (2005) cited as Ref 735 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Miettinen M
0 references
Lasota J
0 references
2005
0 references
Appl. Immunohistochem. Mol. Morphol.
0 references
